CHARM, or Cryosection Histopathology Assessment and Review Machine, is an artificial intelligence (AI) system that is being developed to help doctors diagnose brain cancer during surgery. CHARM uses machine learning to analyze cryosection images of tissue samples, which are thin slices of tissue that are frozen and then cut. This allows CHARM to identify cancer cells, predict genetic mutation status, and classify WHO-defined cancer subtypes.
CHARM has the potential to improve the accuracy and efficiency of brain cancer diagnosis during surgery. Currently, doctors typically rely on frozen section analysis, which is a manual process that can be time-consuming and inaccurate. CHARM could automate this process and provide doctors with more accurate information about the tumor, which could help them make better decisions about treatment.
CHARM is still under development, but it has shown promising results in early studies. In a study published in the journal Med, CHARM was able to accurately identify cancer cells and predict genetic mutation status with a high degree of accuracy. The study also found that CHARM could be used to classify WHO-defined cancer subtypes with a high degree of accuracy.
If CHARM is able to demonstrate its effectiveness in further studies, it could have a significant impact on the treatment of brain cancer. It could help doctors make more accurate diagnoses during surgery, which could lead to better outcomes for patients.
Here are some of the benefits of using CHARM:
- Increased accuracy: CHARM has been shown to be more accurate than traditional methods of brain cancer diagnosis, such as frozen section analysis.
- Reduced time to diagnosis: CHARM can provide doctors with a diagnosis in a matter of minutes, while traditional methods can take hours or even days.
- Improved decision-making: CHARM can provide doctors with more information about the tumor, which can help them make better decisions about treatment.
- Potential to improve patient outcomes: By providing doctors with more accurate and timely information, CHARM has the potential to improve patient outcomes.
Overall, CHARM is a promising new technology with the potential to revolutionize the way brain cancer is diagnosed and treated. It is still under development, but it has shown promising results in early studies. If CHARM is able to demonstrate its effectiveness in further studies, it could have a significant impact on the treatment of brain cancer.
AI shows potential in treating brain cancer.
The AI tool called CHARM has demonstrated the potential to assist doctors with aggressive brain tumors by identifying critical characteristics to guide surgery.
Key points:
-It can quickly discern the genetic profile of a glioma… pic.twitter.com/IYEsAjQp7E— Rowan Cheung (@rowancheung) July 9, 2023